Literature DB >> 32755751

Dissecting the antibody-OME: past, present, and future.

Carolin Loos1, Douglas A Lauffenburger2, Galit Alter3.   

Abstract

Humoral immunity is key to protection for nearly all licensed vaccines. Yet, the design of vaccines has been more difficult for some of our most deadly killers (e.g. HIV, influenza, Dengue virus, etc.), likely due to our incomplete understanding of the precise immunological mechanisms associated with protection. Humoral immunity is governed both by B-cells and their bi-functional secreted antibodies, all of which have a unique capacity to evolve during an immune response. Current OMIC technologies capture individual features of the humoral immune response, providing a glimpse into humoral components (Fab/Fc/B-cell-omic), but fail to provide a wholistic view of the humoral response as a collective functional arm. Here, we dissect current OMIC strategies reviewing experimental and computational approaches, that if integrated could provide a true systems-level view of the humoral immune response.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32755751     DOI: 10.1016/j.coi.2020.06.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  3 in total

Review 1.  Why current quantitative serology is not quantitative and how systems immunology could provide solutions.

Authors:  József Prechl
Journal:  Biol Futur       Date:  2021-02-20

2.  Avidity of Polyclonal Antibodies to Foot-and-Mouth Disease Virus in Bovine Serum Measured Using Bio-Layer Interferometry.

Authors:  Andrew E Shaw; Alison Burman; Amin Asfor; Emiliana Brocchi; Santina Grazioli; Clare Browning; Anna Ludi; Tobias J Tuthill; Donald P King
Journal:  Viruses       Date:  2022-03-29       Impact factor: 5.818

Review 3.  Immunity to SARS-CoV-2: Lessons Learned.

Authors:  Jaime Fergie; Amit Srivastava
Journal:  Front Immunol       Date:  2021-03-19       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.